PubMed:33244056
Annnotations
CL-cell
{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":999,"end":1009},"obj":"Cell"},{"id":"T2","span":{"begin":1177,"end":1187},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000062"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000062"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":42,"end":55},"obj":"Disease"},{"id":"T2","span":{"begin":85,"end":107},"obj":"Disease"},{"id":"T3","span":{"begin":112,"end":129},"obj":"Disease"},{"id":"T4","span":{"begin":140,"end":153},"obj":"Disease"},{"id":"T5","span":{"begin":201,"end":223},"obj":"Disease"},{"id":"T6","span":{"begin":225,"end":228},"obj":"Disease"},{"id":"T7","span":{"begin":245,"end":248},"obj":"Disease"},{"id":"T8","span":{"begin":263,"end":280},"obj":"Disease"},{"id":"T9","span":{"begin":282,"end":284},"obj":"Disease"},{"id":"T10","span":{"begin":413,"end":416},"obj":"Disease"},{"id":"T11","span":{"begin":421,"end":423},"obj":"Disease"},{"id":"T12","span":{"begin":579,"end":582},"obj":"Disease"},{"id":"T13","span":{"begin":615,"end":617},"obj":"Disease"},{"id":"T14","span":{"begin":673,"end":676},"obj":"Disease"},{"id":"T15","span":{"begin":679,"end":681},"obj":"Disease"},{"id":"T16","span":{"begin":684,"end":687},"obj":"Disease"},{"id":"T17","span":{"begin":690,"end":692},"obj":"Disease"},{"id":"T18","span":{"begin":720,"end":723},"obj":"Disease"},{"id":"T19","span":{"begin":726,"end":728},"obj":"Disease"},{"id":"T20","span":{"begin":741,"end":744},"obj":"Disease"},{"id":"T21","span":{"begin":747,"end":749},"obj":"Disease"},{"id":"T22","span":{"begin":790,"end":793},"obj":"Disease"},{"id":"T23","span":{"begin":796,"end":798},"obj":"Disease"},{"id":"T24","span":{"begin":888,"end":890},"obj":"Disease"},{"id":"T25","span":{"begin":895,"end":898},"obj":"Disease"},{"id":"T26","span":{"begin":907,"end":920},"obj":"Disease"},{"id":"T27","span":{"begin":962,"end":965},"obj":"Disease"},{"id":"T28","span":{"begin":968,"end":970},"obj":"Disease"},{"id":"T29","span":{"begin":1072,"end":1075},"obj":"Disease"},{"id":"T30","span":{"begin":1078,"end":1080},"obj":"Disease"},{"id":"T31","span":{"begin":1232,"end":1245},"obj":"Disease"},{"id":"T32","span":{"begin":1315,"end":1318},"obj":"Disease"},{"id":"T33","span":{"begin":1323,"end":1325},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0002123"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0002123"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0002123"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0002123"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}
Anatomy-MAT
{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":93,"end":99},"obj":"Body_part"},{"id":"T2","span":{"begin":209,"end":215},"obj":"Body_part"},{"id":"T3","span":{"begin":924,"end":930},"obj":"Body_part"},{"id":"T4","span":{"begin":1259,"end":1264},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000119"},{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000119"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000035"},{"id":"A4","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A5","pred":"mat_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}
NCBITAXON
{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":475,"end":479},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":538,"end":542},"obj":"OrganismTaxon"},{"id":"T5","span":{"begin":573,"end":577},"obj":"OrganismTaxon"},{"id":"T7","span":{"begin":609,"end":613},"obj":"OrganismTaxon"},{"id":"T9","span":{"begin":667,"end":671},"obj":"OrganismTaxon"},{"id":"T11","span":{"begin":693,"end":697},"obj":"OrganismTaxon"},{"id":"T13","span":{"begin":750,"end":754},"obj":"OrganismTaxon"},{"id":"T15","span":{"begin":828,"end":832},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"10114"},{"id":"A2","pred":"db_id","subj":"T1","obj":"10116"},{"id":"A3","pred":"db_id","subj":"T3","obj":"10114"},{"id":"A4","pred":"db_id","subj":"T3","obj":"10116"},{"id":"A5","pred":"db_id","subj":"T5","obj":"10114"},{"id":"A6","pred":"db_id","subj":"T5","obj":"10116"},{"id":"A7","pred":"db_id","subj":"T7","obj":"10114"},{"id":"A8","pred":"db_id","subj":"T7","obj":"10116"},{"id":"A9","pred":"db_id","subj":"T9","obj":"10114"},{"id":"A10","pred":"db_id","subj":"T9","obj":"10116"},{"id":"A11","pred":"db_id","subj":"T11","obj":"10114"},{"id":"A12","pred":"db_id","subj":"T11","obj":"10116"},{"id":"A13","pred":"db_id","subj":"T13","obj":"10114"},{"id":"A14","pred":"db_id","subj":"T13","obj":"10116"},{"id":"A15","pred":"db_id","subj":"T15","obj":"10114"},{"id":"A16","pred":"db_id","subj":"T15","obj":"10116"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":93,"end":99},"obj":"Body_part"},{"id":"T2","span":{"begin":209,"end":215},"obj":"Body_part"},{"id":"T3","span":{"begin":999,"end":1009},"obj":"Body_part"},{"id":"T4","span":{"begin":1177,"end":1187},"obj":"Body_part"},{"id":"T5","span":{"begin":1259,"end":1264},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000062"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL_0000062"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}
HP-phenotype
{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":13,"end":29},"obj":"Phenotype"},{"id":"T2","span":{"begin":33,"end":55},"obj":"Phenotype"},{"id":"T3","span":{"begin":85,"end":107},"obj":"Phenotype"},{"id":"T4","span":{"begin":112,"end":129},"obj":"Phenotype"},{"id":"T5","span":{"begin":131,"end":153},"obj":"Phenotype"},{"id":"T6","span":{"begin":155,"end":157},"obj":"Phenotype"},{"id":"T7","span":{"begin":201,"end":223},"obj":"Phenotype"},{"id":"T8","span":{"begin":225,"end":228},"obj":"Phenotype"},{"id":"T9","span":{"begin":245,"end":248},"obj":"Phenotype"},{"id":"T10","span":{"begin":263,"end":280},"obj":"Phenotype"},{"id":"T11","span":{"begin":282,"end":284},"obj":"Phenotype"},{"id":"T12","span":{"begin":301,"end":303},"obj":"Phenotype"},{"id":"T13","span":{"begin":328,"end":330},"obj":"Phenotype"},{"id":"T14","span":{"begin":413,"end":416},"obj":"Phenotype"},{"id":"T15","span":{"begin":421,"end":423},"obj":"Phenotype"},{"id":"T16","span":{"begin":442,"end":458},"obj":"Phenotype"},{"id":"T17","span":{"begin":579,"end":582},"obj":"Phenotype"},{"id":"T18","span":{"begin":615,"end":617},"obj":"Phenotype"},{"id":"T19","span":{"begin":673,"end":676},"obj":"Phenotype"},{"id":"T20","span":{"begin":679,"end":681},"obj":"Phenotype"},{"id":"T21","span":{"begin":684,"end":687},"obj":"Phenotype"},{"id":"T22","span":{"begin":690,"end":692},"obj":"Phenotype"},{"id":"T23","span":{"begin":720,"end":723},"obj":"Phenotype"},{"id":"T24","span":{"begin":726,"end":728},"obj":"Phenotype"},{"id":"T25","span":{"begin":741,"end":744},"obj":"Phenotype"},{"id":"T26","span":{"begin":747,"end":749},"obj":"Phenotype"},{"id":"T27","span":{"begin":790,"end":793},"obj":"Phenotype"},{"id":"T28","span":{"begin":796,"end":798},"obj":"Phenotype"},{"id":"T29","span":{"begin":888,"end":890},"obj":"Phenotype"},{"id":"T30","span":{"begin":895,"end":898},"obj":"Phenotype"},{"id":"T31","span":{"begin":907,"end":930},"obj":"Phenotype"},{"id":"T32","span":{"begin":962,"end":965},"obj":"Phenotype"},{"id":"T33","span":{"begin":968,"end":970},"obj":"Phenotype"},{"id":"T34","span":{"begin":978,"end":994},"obj":"Phenotype"},{"id":"T35","span":{"begin":1072,"end":1075},"obj":"Phenotype"},{"id":"T36","span":{"begin":1078,"end":1080},"obj":"Phenotype"},{"id":"T37","span":{"begin":1159,"end":1175},"obj":"Phenotype"},{"id":"T38","span":{"begin":1254,"end":1272},"obj":"Phenotype"},{"id":"T39","span":{"begin":1315,"end":1318},"obj":"Phenotype"},{"id":"T40","span":{"begin":1323,"end":1325},"obj":"Phenotype"},{"id":"T41","span":{"begin":1333,"end":1335},"obj":"Phenotype"},{"id":"T42","span":{"begin":1369,"end":1385},"obj":"Phenotype"},{"id":"T43","span":{"begin":1426,"end":1428},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0025464"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0004934"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0012622"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0000819"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0004934"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"HP:0004934"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"HP:0012622"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"HP:0012622"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"HP:0012622"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0000819"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"HP:0000819"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"HP:0004934"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"HP:0004934"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"HP:0012622"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"HP:0000819"},{"id":"A16","pred":"hp_id","subj":"T16","obj":"HP:0025464"},{"id":"A17","pred":"hp_id","subj":"T17","obj":"HP:0012622"},{"id":"A18","pred":"hp_id","subj":"T18","obj":"HP:0000819"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"HP:0012622"},{"id":"A20","pred":"hp_id","subj":"T20","obj":"HP:0000819"},{"id":"A21","pred":"hp_id","subj":"T21","obj":"HP:0012622"},{"id":"A22","pred":"hp_id","subj":"T22","obj":"HP:0000819"},{"id":"A23","pred":"hp_id","subj":"T23","obj":"HP:0012622"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"HP:0000819"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"HP:0012622"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"HP:0000819"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"HP:0012622"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"HP:0000819"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"HP:0000819"},{"id":"A30","pred":"hp_id","subj":"T30","obj":"HP:0012622"},{"id":"A31","pred":"hp_id","subj":"T31","obj":"HP:0004963"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"HP:0012622"},{"id":"A33","pred":"hp_id","subj":"T33","obj":"HP:0000819"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"HP:0025464"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"HP:0012622"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"HP:0000819"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"HP:0025464"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"HP:0003074"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"HP:0012622"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"HP:0000819"},{"id":"A41","pred":"hp_id","subj":"T41","obj":"HP:0004934"},{"id":"A42","pred":"hp_id","subj":"T42","obj":"HP:0025464"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"HP:0004934"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.\nVascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression."}